Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.68B |
| 2 |
Microsoft
MSFT
|
+$863M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$617M |
| 4 |
Home Depot
HD
|
+$538M |
| 5 |
NVIDIA
NVDA
|
+$433M |
Top Sells
| 1 |
Tesla
TSLA
|
+$643M |
| 2 |
Linde
LIN
|
+$389M |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
+$300M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
+$289M |
| 5 |
Netflix
NFLX
|
+$278M |
Sector Composition
| 1 | Technology | 18% |
| 2 | Healthcare | 15.97% |
| 3 | Consumer Discretionary | 11.04% |
| 4 | Industrials | 10.88% |
| 5 | Financials | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3701
LAVA Therapeutics
LVTX
$40.5M
| $163K | ﹤0.01% |
+80,374
| New | +$163K |
|
3702
WideOpenWest
WOW
$443M
| $163K | ﹤0.01% |
19,326
-162,426
| -89% | -$1.37M |
|
3703
Hudson Technologies
HDSN
$456M
| $162K | ﹤0.01% |
16,888
+6,540
| +63% | +$62.9K |
|
3704
Aurinia Pharmaceuticals
AUPH
$1.69B
| $162K | ﹤0.01% |
16,731
-36,045
| -68% | -$349K |
|
|
NEWP
3705
New Pacific Metals
NEWP
$382M
| $162K | ﹤0.01% |
74,633
+27,864
| +60% | +$60.4K |
|
3706
Q32 Bio
QTTB
$22.1M
| $161K | ﹤0.01% |
10,112
-1,537
| -13% | -$24.5K |
|
3707
CEL-SCI Corp
CVM
$67.9M
| $161K | ﹤0.01% |
2,225
-1,627
| -42% | -$118K |
|
3708
Generation Bio
GBIO
$37.7M
| $161K | ﹤0.01% |
2,919
-1,013
| -26% | -$55.7K |
|
|
BFX
3709
DELISTED
BowFlex Inc.
BFX
| $159K | ﹤0.01% |
130,700
-20,529
| -14% | -$25K |
|
3710
AerSale
ASLE
$407M
| $159K | ﹤0.01% |
+10,842
| New | +$159K |
|
3711
PepGen
PEPG
$52.2M
| $159K | ﹤0.01% |
17,730
+7,280
| +70% | +$65.1K |
|
|
IPHA
3712
Innate Pharma
IPHA
$191M
| $155K | ﹤0.01% |
49,450
-12,449
| -20% | -$39.1K |
|
3713
Origin Materials
ORGN
$79.2M
| $155K | ﹤0.01% |
36,328
-491,910
| -93% | -$2.1M |
|
3714
Grupo Aval
AVAL
$3.97B
| $154K | ﹤0.01% |
66,511
+55,458
| +502% | +$129K |
|
3715
TOP Financial Group
TOP
$47.8M
| $154K | ﹤0.01% |
16,429
-13,127
| -44% | -$123K |
|
3716
AEye
LIDR
$108M
| $154K | ﹤0.01% |
+28,416
| New | +$154K |
|
3717
Scholar Rock
SRRK
$3.24B
| $152K | ﹤0.01% |
20,223
-496,024
| -96% | -$3.74M |
|
3718
AC Immune
ACIU
$249M
| $152K | ﹤0.01% |
51,532
-67,495
| -57% | -$199K |
|
3719
Southern California Bancorp
BCAL
$559M
| $151K | ﹤0.01% |
+11,032
| New | +$151K |
|
|
USBC
3720
USBC, Inc.
USBC
$285M
| $151K | ﹤0.01% |
3,736
-330
| -8% | -$13.3K |
|
3721
Westwood Holdings Group
WHG
$161M
| $149K | ﹤0.01% |
12,015
-3,334
| -22% | -$41.3K |
|
|
CLCO
3722
Cool Company
CLCO
$416M
| $149K | ﹤0.01% |
+10,864
| New | +$149K |
|
3723
Stereotaxis
STXS
$257M
| $148K | ﹤0.01% |
96,910
-490,095
| -83% | -$750K |
|
|
RWT
3724
Redwood Trust
RWT
$793M
| $148K | ﹤0.01% |
23,211
-19,103
| -45% | -$122K |
|
3725
Precision BioSciences
DTIL
$53M
| $148K | ﹤0.01% |
9,363
-67,128
| -88% | -$1.06M |
|